Recombinant Human Anti-CD8 x Human Anti-PSCA Bispecific Antibody (scFv-Fc) (BSCFV-H304)

Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD8 specificity or anti-PSCA specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Datasheet INQUIRY

Specifications

Targets

CD8 & PSCA

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Prostate cancer

Targets

Target 1

CD8

Gene ID

925

UniProt ID

P01732

Alternative Names

CD8A; CD8a molecule; Cluster of differentiation 8; CD8; MAL; p32; Leu2

Target 2

PSCA

Gene ID

8000

UniProt ID

D3DWI6

Alternative Names

PSCA; prostate stem cell antigen; PRO232

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD8 x Human Anti-PSCA Bispecific Antibody (scFv-Fc) (BSCFV-H304). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD8 x Human Anti-PSCA Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-H304)

Specifications

Targets

Customer Reviews and Q&As